Idiopathic Inflammatory Myopathy
📧 Sign up to get email alerts when something new happens for Idiopathic Inflammatory Myopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-24Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy. [Phase 2, Phase 3]
A Phase 2/3 trial evaluating the efficacy and safety of Efgartigimod PH20 SC in adults with active idiopathic inflammatory myopathy has comp…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Assessment of Safety and Acute Effects of a Knee-hip Powered Soft Exoskeleton in Patients With Neuromuscular Disorders [NA]
A completed clinical trial evaluating the safety and acute effects of a knee-hip powered soft exoskeleton in people with neuromuscular disor…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Assessment of Safety and Acute Effects of a Lower-limb Powered Dermoskeleton in Patients With Neuromuscular Disorders [NA]
A completed clinical trial assessing safety and acute effects of a lower-limb powered dermoskeleton in patients with neuromuscular disorders…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Muscle Function and Effects of Repetitive Task Training in Patients With Inflammatory Myopaties [NA]
This completed clinical trial evaluated muscle function and the effects of repetitive task training in patients with inflammatory myopathies…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: TELITACICEPT IN INFLAMMATORY MYOPATHIES(TELITACICEPT-IM) [Phase 2, Phase 3]
A Phase 2/Phase 3 study of Telitacicept in inflammatory myopathies is not yet recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune Diseases [EARLY_Phase 1]
An early Phase 1 clinical trial evaluating the safety and efficacy of a targeted BCMA in vivo lentiviral vector injection for recurrent or r…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1) [Phase 1]
Phase 1 Breakfree-1 trial evaluating CC-97540, a CD-19-targeted Nex-T CAR T cell therapy, for severe, refractory autoimmune diseases; the st…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease [Phase 1]
A Phase 1 safety and efficacy study of CTX112 in adults with refractory autoimmune diseases, including systemic lupus erythematosus and syst…
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: OM336 in Seropositive Autoimmune Diseases [Phase 1]
Phase 1 trial update for OM336 in seropositive autoimmune diseases; the study in Sjögren's syndrome and idiopathic inflammatory myopathy is …
-
CLINICAL_TRIALS trial_result · 2025-11-03Clinical Trial Update: A Phase 2 Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM) [Phase 2]
Amgen completed a Phase 2 proof-of-concept trial evaluating the efficacy and safety of Daxdilimab in Dermatomyositis and anti-synthetase inf…
-
CLINICAL_TRIALS trial_result · 2021-11-22Clinical Trial Update: Clinical Study of MMF in Treatment of IIM-ILD and Its Effect on Peripheral Blood Treg Cells [Phase 4]
A Phase 4 clinical trial evaluating mycophenolate mofetil (MMF) in treating idiopathic inflammatory myopathy-associated interstitial lung di…
-
CLINICAL_TRIALS trial_result · 2018-08-06Clinical Trial Update: Stem Cell Transplantation in Idiopathic Inflammatory Myopathy Diseases [Phase 1]
Phase 1 trial update on stem cell transplantation for idiopathic inflammatory myopathy diseases, terminated with results posted in 2018.